Eagle Capital Management, LLC Abb Vie Inc. Transaction History

Eagle Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $2.65 Million - $3.27 Million	-34,102 Closed	0 $0
Q3 2018 Oct 12, 2018	BUY	$88.91 - $98.84 $68,371 - $76,007	769 Added 2.31%	34,102 $3.23 Million
Q2 2018 Jul 19, 2018	BUY	$89.78 - $106.23 $38,515 - $45,572	429 Added 1.3%	33,333 $3.09 Million
Q1 2018 Apr 09, 2018	SELL	$92.01 - $123.21 $826,617 - $1.11 Million	-8,984 Reduced 21.45%	32,904 $3.11 Million
Q4 2017 Jan 19, 2018	SELL	$89.56 - $98.21 $41,108 - $45,078	-459 Reduced 1.08%	41,888 $4.05 Million
Q3 2017 Oct 16, 2017	BUY	$69.85 - $89.22 $2.96 Million - $3.78 Million	42,347	42,347 $3.76 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Eagle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Capital Management, LLC with notifications on news.